Venture capital fund · 1 deal
Every published round UniQuest Extension Fund took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| On The House | Seed | Jan 2026 | $1.7m | Participant | Startup Daily (12 Jun 2026), SmartCompany (12 Jun 2026), Women's Agenda, Missing Perspectives, Startup Daily (30 Jan 2026), SmartCompany (30 Jan 2026), Startup Daily (27 Jan 2026) |
Companies UniQuest Extension Fund has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| On The House | Free period product dispenser | Jan 2026, Seed | 1 | 0 |
Fund closes reported for UniQuest Extension Fund, as distinct from the investments it has made.
Companies UniQuest Extension Fund has backed that another company then bought. An exit for the holding, not a deal UniQuest Extension Fund did.
Stories naming UniQuest Extension Fund. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Uniseed-backed Australian medtech Q-Sera's blood-clotting tube technology has debuted in Japan via Terumo's VenoJect II launch; the post also credits MRCF and UniQuest Extension Fund as backers.
FaBA profiles Pollinate, a Brisbane startup founded by Adeep Mitra and Corey Berther that uses AI to automate food supply chain workflows, tracing its path from a university food challenge to Y Combinator backing.
Q-Sera's rapid-clotting blood tube technology has gone to market in Japan via Terumo's VenoJect II launch; the Melbourne startup's backers include MRCF, Uniseed and the UniQuest Extension Fund.
Roundup of six Australian funding deals: AutoGrab, Applied EV, Checkbox, Hometime, Factory and On the House, with amounts, investors, and Hometime's past acquisitions and raise history detailed.
Also Startup Daily
On the House, a Brisbane startup founded by a Startmate alumna, has secured $1.7 million in a Purpose Ventures-led seed round to expand its ad-funded dispensers offering free period products nationally.
Also SmartCompany·Startup Daily·SmartCompany·Startup Daily·Missing Perspectives·Women's Agenda
Queensland drug developer Lucia Bio added $2 million to its seed round from UniQuest Extension Fund and Uniseed-managed funds, bringing its overall raise to $3 million ahead of a planned Series A.
Molecule to Medicine announces Curlew Bio as the second venture in its Brisbane Pod, with Uniquest Expansion Fund backing, to develop immunological therapies for inflammatory disease.
UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.